Lungpacer Medical

company

About

Lungpacer Medical develops a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle.

  • 51 - 100

Details

Last Funding Type
Angel
Industries
Biotechnology,Health Care,Medical Device
Founded date
Jan 1, 2009
Number Of Employee
51 - 100
Operating Status
Active

Lungpacer Medical is developing a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle The objective of the company is to develop and commercialize a novel therapeutic solution that addresses the significant health and cost issues associated with mechanical ventilation of critically ill patients in hospital Intensive Care Units (ICU). It is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach that is expected to save many lives, improve surviving patient outcomes and greatly reduce hospital care costs.

In addition, the paced diaphragm is expected to restore negative pressure ventilation, thereby potentially providing a more physiological respiratory pattern and reducing the levels of positive pressure ventilation and its harmful effects on the lungs.

Lung Pacer was founded in 2009 and is headquartered in Vancouver, British Columbia, Canada.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Lungpacer Medical has raised a total of — in funding over 2 rounds. Their latest funding was raised on Dec 1, 2016 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 1, 2016 Angel 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Lungpacer Medical is funded by 1 investors. Keiretsu Forum are the most recent investors.
Investor Name Lead Investor Funding Round
Keiretsu Forum Angel